This content is current only at the time of printing. This document was printed on 25 February 2020. A current copy is located at https://apvma.gov.au/node/20686
You are here
Proposed approval of human insulin and registration of the product prozinc insulin injection for cats
This consultation closed on 18 October 2016.
The APVMA is considering an application for the approval of human insulin and registration of prozinc insulin injection for cats. The product is proposed to be registered for the treatment of diabetes mellitus in cats to achieve reduction of hyperglycaemia and improvement of associated clinical signs.
We invite comment from 20 September 2016 to 18 October 2016 on whether the application for approval of the active constituent and/or registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds for registration, including:
- safety criteria
- efficacy criteria
- trade criteria.
For more information see page 22 of Gazette No. 19 from 20 September 2016.
Please send your written submission by email, post or fax to:
Registration Management and Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604
Fax: +61 2 6210 4721
Phone: +61 2 6210 4701